European Journal of Surgical Oncology
Volume 38, Issue 2 , Pages 95-109 , February 2012

The accuracy of sentinel node biopsy in breast cancer patients with the history of previous surgical biopsy of the primary lesion: Systematic review and meta-analysis of the literature

  • H. Javan

      Affiliations

    • Surgical Oncology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
    • ,
  • H. Gholami

      Affiliations

    • Meta-analysis Subgroup, Evidence Based Medicine Committee, Mashhad University of Medical Sciences, Mashhad, Iran
    • ,
  • M. Assadi

      Affiliations

    • Surgical Oncology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
    • ,
  • A. Fani Pakdel

      Affiliations

    • Cancer Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
    • ,
  • R. Sadeghi

      Affiliations

    • Meta-analysis Subgroup, Evidence Based Medicine Committee, Mashhad University of Medical Sciences, Mashhad, Iran
    • Nuclear Medicine Research Center, Mashhad University of Medical Sciences, Faculty of Medicine, Imam Reza Hospital, Mashhad, Iran
    • Corresponding Author InformationCorresponding author. Nuclear Medicine Research Center, Mashhad University of Medical Sciences, Faculty of Medicine, Imam Reza Hospital, Ebn Sina St, Mashhad, Iran. Tel.: +98 511 8022729; fax: +98 511 8599359.
    • ,
  • M. Keshtgar

      Affiliations

    • Consultant Surgical Oncologist, Royal Free Hospital and University College London, London, United Kingdom

,Accepted 15 November 2011.

References 

  1. Vidal-Sicart S, Rioja Martin ME. Scintigraphic and intraoperative detection of the sentinel lymph node in breast cancer. Rev Esp Med Nucl. 2009;28:41–43
  2. Wood BC, David LR, Defranzo AJ, et al. Impact of sentinel lymph node biopsy on immediate breast reconstruction after mastectomy. Am Surg. 2009;75:551–556[discussion 6–7]
  3. Imasato M, Shimazu K, Tamaki Y, et al. Long-term follow-up results of breast cancer patients with sentinel lymph node biopsy using periareolar injection. Am J Surg;199:442–6.
  4. Bergkvist L. Resolving the controversies surrounding lymphatic mapping in breast cancer. Future Oncol. 2008;4:681–688
  5. Koukouraki S, Sanidas E, Askoxilakis J, et al. Is there any benefit from sentinel lymph node biopsy using the combined radioisotope/dye technique in breast cancer patients with clinically negative axilla?. Nucl Med Commun. 2009;30:48–53
  6. Climaco F, Coelho-Oliveira A, Djahjah MC, et al. Sentinel lymph node identification in breast cancer: a comparison study of deep versus superficial injection of radiopharmaceutical. Nucl Med Commun. 2009;30:525–532
  7. Seok JW, Kim IJ, Heo YJ, et al. Comparison of subareolar injection lymphoscintigraphy with the 1-day and the 2-day protocols for the detection of sentinel lymph nodes in patients with breast cancer. Ann Nucl Med. 2009;23:465–469
  8. Abdollahi A, Jangjoo A, Dabbagh Kakhki VR, et al. Factors affecting sentinel lymph node detection failure in breast cancer patients using intradermal injection of the tracer. Rev Esp Med Nucl. 2010;29:73–77
  9. Feldman SM, Krag DN, McNally RK, Moor BB, Weaver DL, Klein P. Limitation in gamma probe localization of the sentinel node in breast cancer patients with large excisional biopsy. J Am Coll Surg. 1999;188:248–254
  10. Miner TJ, Shriver CD, Jaques DP, Maniscalco-Theberge ME, Krag DN. Sentinel lymph node biopsy for breast cancer: the role of previous biopsy on patient eligibility. Am Surg. 1999;65:493–498[discussion 8–9]
  11. Haigh PI, Hansen NM, Qi K, Giuliano AE. Biopsy method and excision volume do not affect success rate of subsequent sentinel lymph node dissection in breast cancer. Ann Surg Oncol. 2000;7:21–27
  12. Sadeghi R, Forghani MN, Memar B, et al. How long the lymphoscintigraphy imaging should be continued for sentinel lymph node mapping?. Ann Nucl Med. 2009;23:507–510
  13. Estourgie SH, Valdes Olmos RA, Nieweg OE, Hoefnagel CA, Rutgers EJ, Kroon BB. Excision biopsy of breast lesions changes the pattern of lymphatic drainage. Br J Surg. 2007;94:1088–1091
  14. Gutwein LG, Ang DN, Liu H, et al. Utilization of minimally invasive breast biopsy for the evaluation of suspicious breast lesions. Am J Surg. 2011;202:127–132
  15. Severi S, Gazzoni E, Pellegrini A, et al. Financial aspects of sentinel lymph node biopsy in early breast cancer. Q J Nucl Med Mol Imaging. 2010;54:
  16. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–188
  17. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–1558
  18. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–634
  19. Duval S, Tweedie R. A nonparametric ‘trim and fill’ method of accounting for publication bias in meta-analysis. J Am Stat Assoc. 2000;95:89–98
  20. Agresti A. The odds ratio. 2nd ed.. John Wiley & Sons, Inc; 2007;
  21. Noguchi M, Motomura K, Imoto S, et al. A multicenter validation study of sentinel lymph node biopsy by the Japanese Breast Cancer Society. Breast Cancer Res Treat. 2000;63:31–40
  22. Tuthill LL, Reynolds HE, Goulet RJ. Biopsy of sentinel lymph nodes guided by lymphoscintigraphic mapping in patients with breast cancer. AJR Am J Roentgenol. 2001;176:407–411
  23. Ishikawa T, Momiyama N, Hamaguchi Y, et al. Blue-dye technique complements four-node sampling for early breast cancer. Eur J Surg Oncol. 2005;31:1119–1124
  24. Birdwell RL, Smith KL, Betts BJ, Ikeda DM, Strauss HW, Jeffrey SS. Breast cancer: variables affecting sentinel lymph node visualization at preoperative lymphoscintigraphy. Radiology. 2001;220:47–53
  25. Kollias J, Gill PG, Coventry BJ, Malycha P, Chatterton B, Farshid G. Clinical and histological factors associated with sentinel node identification in breast cancer. Aust N Z J Surg. 2000;70:485–489
  26. Martin RC, Chagpar A, Scoggins CR, et al. Clinicopathologic factors associated with false-negative sentinel lymph-node biopsy in breast cancer. Ann Surg. 2005;241:1005–1012
  27. Cody HS, Fey J, Akhurst T, et al. Complementarity of blue dye and isotope in sentinel node localization for breast cancer: univariate and multivariate analysis of 966 procedures. Ann Surg Oncol. 2001;8:13–19
  28. Ahrendt GM, Laud P, Tjoe J, et al. Does breast tumor location influence success of sentinel lymph node biopsy?. J Am Coll Surg. 2002;194:278–284
  29. Straalman K, Kristoffersen US, Galatius H, Lanng C. Factors influencing sentinel lymph node identification failure in breast cancer surgery. Breast. 2008;17:167–171
  30. Chagpar AB, Martin RC, Scoggins CR, et al. Factors predicting failure to identify a sentinel lymph node in breast cancer. Surgery. 2005;138:56–63
  31. Shivers S, Cox C, Leight G, et al. Final results of the Department of Defense multicenter breast lymphatic mapping trial. Ann Surg Oncol. 2002;9:248–255
  32. Borgstein PJ, Meijer S, Pijpers RJ, van Diest PJ. Functional lymphatic anatomy for sentinel node biopsy in breast cancer: echoes from the past and the periareolar blue method. Ann Surg. 2000;232:81–89
  33. Bembenek A, Fischer J, Albrecht H, et al. Impact of patient- and disease-specific factors on SLNB in breast cancer patients. Are current guidelines justified?. World J Surg. 2007;31:267–275
  34. Nason KS, Anderson BO, Byrd DR, et al. Increased false negative sentinel node biopsy rates after preoperative chemotherapy for invasive breast carcinoma. Cancer. 2000;89:2187–2194
  35. Jablon LK, Namjoshi SD, Braitman LE, Somers RG. Influence of initial biopsy technique on the ability to identify sentinel nodes in breast cancer patients. Breast J. 2005;11:224
  36. Layeeque R, Kepple J, Henry-Tillman RS, et al. Intraoperative subareolar radioisotope injection for immediate sentinel lymph node biopsy. Ann Surg. 2004;239:841–845
  37. Morrow M, Rademaker AW, Bethke KP, et al. Learning sentinel node biopsy: results of a prospective randomized trial of two techniques. Surgery. 1999;126:714–720
  38. Zervos EE, Burak WE. Lymphatic mapping for breast cancer: experience at The Ohio State University. Breast Cancer. 2000;7:195–200
  39. Tafra L, Lannin DR, Swanson MS, et al. Multicenter trial of sentinel node biopsy for breast cancer using both technetium sulfur colloid and isosulfan blue dye. Ann Surg. 2001;233:51–59
  40. Dede F, Gulluoglu BM, Ones T, et al. Multiparametric analysis of preoperative lymphatic mapping with the use of combined deep plus superficial radiotracer injection technique in early breast cancer. Nucl Med Commun. 2008;29:546–552
  41. Chua B, Olivotto IA, Donald JC, et al. Outcomes of sentinel node biopsy for breast cancer in British Columbia, 1996 to 2001. Am J Surg. 2003;185:118–126
  42. Yararbas U, Argon AM, Yeniay L, Kapkac M. Problematic aspects of sentinel lymph node biopsy and its relation to previous excisional biopsy in breast cancer. Clin Nucl Med. 2009;34:854–858
  43. Lo YF, Hsueh S, Ma SY, Chen SC, Chen MF. Radioguided sentinel lymph node biopsy in early breast cancer: experience at Chang Gung Memorial Hospital. Chang Gung Med J. 2006;29:458–467
  44. Krag DN, Harlow S, Weaver D, Ashikaga T. Radiolabeled sentinel node biopsy: collaborative trial with the National Cancer Institute. World J Surg. 2001;25:823–828
  45. Heuts EM, van der Ent FW, Kengen RA, van der Pol HA, Hulsewe KW, Hoofwijk AG. Results of sentinel node biopsy not affected by previous excisional biopsy. Eur J Surg Oncol. 2006;32:278–281
  46. Borgstein PJ, Pijpers R, Comans EF, van Diest PJ, Boom RP, Meijer S. Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg. 1998;186:275–283
  47. Nwariaku FE, Euhus DM, Beitsch PD, et al. Sentinel lymph node biopsy, an alternative to elective axillary dissection for breast cancer. Am J Surg. 1998;176:529–531
  48. Eary JF, Mankoff DA, Dunnwald LK, et al. Sentinel lymph node mapping for breast cancer: analysis in a diverse patient group. Radiology. 1999;213:526–529
  49. Ohtake E, Asaga T, Inaba M. Sentinel lymphoscintigraphy in patients with breast cancer undergoing excisional biopsy. Ann Nucl Med. 2005;19:671–675
  50. Barnwell JM, Arredondo MA, Kollmorgen D, et al. Sentinel node biopsy in breast cancer. Ann Surg Oncol. 1998;5:126–130
  51. Celebioglu F, Frisell J, Danielsson R, Bergkvist L. Sentinel node biopsy in non-palpable breast cancer and in patients with a previous diagnostic excision. Eur J Surg Oncol. 2007;33:276–280
  52. Posther KE, McCall LM, Blumencranz PW, et al. Sentinel node skills verification and surgeon performance: data from a multicenter clinical trial for early-stage breast cancer. Ann Surg. 2005;242:593–599
  53. Kuehn T, Vogl FD, Helms G, et al. Sentinel-node biopsy for axillary staging in breast cancer: results from a large prospective German multi-institutional trial. Eur J Surg Oncol. 2004;30:252–259
  54. Noguchi M, Bando E, Tsugawa K, et al. Staging efficacy of breast cancer with sentinel lymphadenectomy. Breast Cancer Res Treat. 1999;57:221–229
  55. Ruano R, Ramos M, Garcia-Talavera JR, et al. Staging the axilla with selective sentinel node biopsy in patients with previous excision of non-palpable and palpable breast cancer. Eur J Nucl Med Mol Imaging. 2008;35:1299–1304
  56. Layeeque R, Henry-Tillman R, Korourian S, Kass R, Klimberg VS. Subareolar sentinel node biopsy for multiple breast cancers. Am J Surg. 2003;186:730–735
  57. Krag DN, Anderson SJ, Julian TB, et al. Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet Oncol. 2007;8:881–888
  58. Patel NA, Dusi D, Bragdon G, Julian TB. Technical limitations of sentinel node biopsy in breast cancer: a single surgeon’s experience. Am Surg. 2003;69:111–116
  59. Wong SL, Edwards MJ, Chao C, et al. The effect of prior breast biopsy method and concurrent definitive breast procedure on success and accuracy of sentinel lymph node biopsy. Ann Surg Oncol. 2002;9:272–277
  60. Leidenius MH, Vironen JH, von Smitten KA, Heikkila PS, Joensuu H. The outcome of sentinel node biopsy in breast cancer patients with preoperative surgical biopsy. J Surg Oncol. 2009;99:420–423
  61. Asoglu O, Ozmen V, Karanlik H, et al. The role of sentinel lymph node biopsy with blue dye alone in breast cancer patients with excisional biopsy. Acta Chir Belg. 2005;105:291–296
  62. Krag D, Weaver D, Ashikaga T, et al. The sentinel node in breast cancer – a multicenter validation study. N Engl J Med. 1998;339:941–946
  63. Forghani MN, Memar B, Jangjoo A, et al. The effect of excisional biopsy on the accuracy of sentinel lymph node mapping in early stage breast cancer: comparison with core needle biopsy. Am Surg. 2010;76:1232–1235
  64. Aliakbarian M, Memar B, Jangjoo A, et al. Factors influencing the time of sentinel node visualization in breast cancer patients using intradermal injection of the radiotracer. Am J Surg. 2011;202:199–202
  65. Bass SS, Lyman GH, McCann CR, et al. Lymphatic mapping and sentinel lymph node biopsy. Breast J. 1999;5:288–295
  66. Roumen RM, Valkenburg JG, Geuskens LM. Lymphoscintigraphy and feasibility of sentinel node biopsy in 83 patients with primary breast cancer. Eur J Surg Oncol. 1997;23:495–502
  67. Kang SH, Lee ES, Kang HS, Ro JS, Lee S, Kang KW. Neoadjuvant chemotherapy decreases the identification rate of sentinel lymph node biopsy. J Korean Breast Cancer Soc. 2003;6:95–102
  68. Maza S, Thomas A, Winzer KJ, et al. Subareolar injection of technetium-99m nanocolloid yields reliable data on the axillary lymph node tumour status in breast cancer patients with previous manipulations on the primary tumour: a prospective study of 117 patients. Eur J Nucl Med Mol Imaging. 2004;31:671–675
  69. Imoto S, Hasebe T. Initial experience with sentinel node biopsy in breast cancer at the National Cancer Center Hospital East. Jpn J Clin Oncol. 1999;29:11–15
  70. Huang XY, Wu J, Liu ZB, et al. Application of methylene blue dye to sentinel lymph node biopsy in breast cancer and its influencing factors. Ai Zheng. 2007;26:1133–1137
  71. Gommans GM, van der Zant FM, van der Schors TG, et al. Effect of increased (99m)Tc/(99)Tc ratios on count rates in sentinel node procedures: a randomised study. Eur J Nucl Med Mol Imaging. 2003;30:1231–1235
  72. Sener SF, Winchester DJ, Brinkmann E, et al. Failure of sentinel lymph node mapping in patients with breast cancer. J Am Coll Surg. 2004;198:732–736
  73. Pritsivelis C, Garcia Mendonca CA, Pinheiro Pessoa MC, Coelho-Oliveira A, Gutfilen B, Barbosa Da Fonseca LM. Failure predictors of the sentinel lymph node in patients with breast cancer using Tc-99m sulfur colloid and periareolar injection. Q J Nucl Med Mol Imaging. 2007;51:189–193
  74. Cox CE, Pendas S, Cox JM, et al. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg. 1998;227:645–651
  75. Rodierl JF, Routiotl T, Mignotte H, et al. Intraoperative lymphatic mapping and sentinel node biopsy in breast cancer. A 128-case feasibility study. Chirurg. 1998;123:239–246
  76. Marchal F, Rauch P, Morel O, et al. Results of preoperative lymphoscintigraphy for breast cancer are predictive of identification of axillary sentinel lymph nodes. World J Surg. 2006;30:55–62
  77. Lamichhane N, Shen KW, Li CL, et al. Sentinel lymph node biopsy in breast cancer patients after overnight migration of radiolabelled sulphur colloid. Postgrad Med J. 2004;80:546–550
  78. Gentilini O, Chagas E, Zurrida S, et al. Sentinel lymph node biopsy in male patients with early breast cancer. Oncologist. 2007;12:512–515
  79. Nos C, Freneaux P, Guilbert S, Falcou MC, Salmon RJ, Clough KB. Sentinel lymph node detection for breast cancer: which patients are best suited for the patent blue dye only method of identification?. Ann Surg Oncol. 2001;8:438–443
  80. Povoski SP, Dauway EL, Ducatman BS. Sentinel lymph node mapping and biopsy for breast cancer at a rural-based university medical center: initial experience with intraparenchymal and intradermal injection routes. Breast Cancer. 2002;9:134–144
  81. Tuttle TM, Colbert M, Christensen R, et al. Subareolar injection of 99mTc facilitates sentinel lymph node identification. Ann Surg Oncol. 2002;9:77–81
  82. Klimberg VS, Rubio IT, Henry R, Cowan C, Colvert M, Korourian S. Subareolar versus peritumoral injection for location of the sentinel lymph node. Ann Surg. 1999;229:860–864
  83. Sanli Y, Berberoglu K, Turkmen C, et al. The value of combined peritumoral and subdermal injection techniques for lymphoscintigraphy in detection of sentinel lymph node in breast cancer. Clin Nucl Med. 2006;31:690–693
  84. Shoher A, Diwan A, Teh BS, Lu HH, Fisher R, Lucci A. Lymphoscintigraphy does not enhance sentinel node identification or alter management of patients with early breast cancer. Curr Surg. 2006;63:207–212
  85. Kesmodel SB, Canter RJ, Terhune KP, et al. Use of radiotracer for sentinel lymph node mapping in breast cancer optimizes staging independent of site of administration. Clin Nucl Med. 2006;31:527–533
  86. Boughey JC, Bedrosian I, Meric-Bernstam F, et al. Comparative analysis of sentinel lymph node operation in male and female breast cancer patients. J Am Coll Surg. 2006;203:475–480
  87. van der Ploeg IM, Nieweg OE, van Rijk MC, Valdes Olmos RA, Kroon BB. Axillary recurrence after a tumour-negative sentinel node biopsy in breast cancer patients: a systematic review and meta-analysis of the literature. Eur J Surg Oncol. 2008;34:1277–1284
  88. Valsamaki P. Lymphatic system and lymphoscintigraphy. Hell J Nucl Med. 2009;12:87–89
  89. Vidal-Sicart S, Domenech B, Lujan B, et al. Sentinel node in gynaecological cancers. Our experience. Rev Esp Med Nucl. 2009;28:221–228
  90. Sadeghi R, Tabasi KT, Bazaz SM, et al. Sentinel node mapping in the prostate cancer. Meta-analysis. Nuklearmedizin. 2011;50:107–115

PII: S0748-7983(11)00693-7

doi: 10.1016/j.ejso.2011.11.005

European Journal of Surgical Oncology
Volume 38, Issue 2 , Pages 95-109 , February 2012

Article Tools

* Image Usage & Resolution